ENDPOINTS

MD Anderson targets $250M for second cancer biotech fund

Headed into the biggest oncology research and development confab of the year, one of the nation’s premier cancer institutions is looking at a hefty second batch of capital to support future drugs in the field ...

May 28, 2025 - 12:04
 0
MD Anderson targets $250M for second cancer biotech fund
Headed into the biggest oncology research and development confab of the year, one of the nation’s premier cancer institutions is looking at a hefty second batch of capital to support future drugs in the field ...
Read More

Tags:

Previous Article

#ASCO25: Strand Therapeutics reports promising start for mRNA cancer therapy

Next Article

Dog owners are willing to pay more for food labeled for certain health attribute...

Related Posts

A new dawn for psychedelics? Compass could be the first to find out

A new dawn for psychedelics? Compass could be the first...

May 28, 2025  0

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-st...

May 14, 2025  0

CellCentric raises $120M to treat multiple myeloma with capsule

CellCentric raises $120M to treat multiple myeloma with...

May 19, 2025  0